This drug class, known as GLP-1 agonists, incorporates semaglutide—authorized as Ozempic for type two diabetes and Wegovy for weight problems—and tirzepatide—accredited as Mounjaro for diabetic issues https://harmonyyjlx386719.blogcudinti.com/profile